Research Paper

D-Allulose: A Review of In Vivo Metabolism, Catalytic Mechanisms, Engineered Strain Construction, and Biosynthesis

What Makes Allulose Different D allulose delivers 70% of the sweetness of sucrose at 0.2 kcal per gram. That is a 95% calorie cut. The FDA already recognizes it as GRAS. A review p

What Makes Allulose Different

D-allulose delivers 70% of the sweetness of sucrose at 0.2 kcal per gram. That is a 95% calorie cut. The FDA already recognizes it as GRAS. A review published in Frontiers in Bioengineering and Biotechnology (DOI: 10.3389/fbioe.2020.00026) lays out how this rare sugar moves through the body, how enzymes build it, and how engineered strains will bring costs down.

Background

D-allulose is a monosaccharide with a clean, sugar-like taste. Sucrose provides 4.0 kcal per gram. Allulose provides 0.2. That difference changes the math for any formulation.

Food brands already use it across several categories. The review identifies beverages, baked goods, ice cream, and yogurt as the primary applications. These are all low-calorie product lines. The physiological side reads just as well. The review ties allulose to improved insulin resistance, better blood sugar control, and reduced abdominal fat accumulation.

What the Study Did

The paper is a comprehensive review. It systematically analyzes the research landscape in three sections. First, the enzymatic characteristics behind allulose production. Second, the construction of engineered microbial strains. Third, the green and circular production technologies that refine the process.

The in vivo metabolism section tracks what happens inside the body. Allulose gets absorbed but behaves unlike conventional sugars. It does not trigger the same glucose response. The review connects those pathways to the clinical outcomes above.

Key Findings

The evidence falls into a clear commercial story. Allulose tastes and performs close enough to sugar that reformulation stays manageable.

Metric Allulose Sucrose
Relative sweetness 70% 100%
Calories per gram 0.2 kcal 4.0 kcal
Calorie reduction vs sucrose 95%
FDA GRAS status Yes Yes
Established applications Beverages, bakery, ice cream, yogurt

The enzymatic work centers on ketose 3-epimerase, the enzyme family that converts fructose into allulose. Researchers have engineered these enzymes for higher activity and stability. The review compares variants from different microbial sources to identify the best performers.

Engineered strains take production one step further. Whole-cell biocatalysts express the epimerase and convert fructose directly. That reduces purification steps and cuts cost. The green production section covers circular strategies: recycling unreacted fructose, reusing immobilized enzymes, and minimizing solvent inputs. These details matter for buyers tracking the price curve.

What It Means for Manufacturers

Beverage formulators get a low-calorie sweetener that does not spike glucose. Bakery producers get functional sugar behavior in dough and batter. Ice cream makers maintain texture in low-calorie formulas. Yogurt formulators get clean sweetness without residual off-notes. All four categories appear as established uses in the review.

Cost remains the main hurdle. The strain engineering and circular production work in this paper are what will close the gap. Buyers should track enzyme productivity and substrate conversion rates. Those two numbers set the wholesale price.

For purchasing decisions, three things matter. Confirm residual fructose levels from the supplier. Ask about enzyme recycling efficiency. Verify the strain platform behind the product. Not all allulose is equal.

FAQ

Does allulose raise blood sugar? No. The review links allulose to better blood sugar control and improved insulin resistance, which fits low-glycemic product claims.

Is allulose GRAS? Yes. FDA GRAS status removes the main regulatory hurdle for food and beverage launches.

Which product categories work best? Beverages, baked goods, ice cream, and yogurt. These appear throughout the review as practical applications.

The allulose story keeps moving fast. Enzyme performance keeps climbing. Strain engineering progresses yearly. The metabolism data supports the health position. For any formulator facing a sugar-reduction deadline, this review gives the technical foundation to act now.

Research Source

DOI: 10.3389/fbioe.2020.00026

View original paper

Need Allulose Application Guidance?

Our technical team can help evaluate allulose for sugar reduction, texture, browning, and label-planning projects.